Sign In
Buy AMRX
$18.09
+0.170 (+0.95%)
At Close: Jul 27, 2026
Royal Bank of Canada Reiterates Hold Rating for Amneal Pharmaceuticals (NYSE:AMRX)
09:58am, Monday, 20'th Apr 2020
Royal Bank of Canada reaffirmed their hold rating on shares of Amneal Pharmaceuticals (NYSE:AMRX) in a research note released on Thursday morning, AnalystRatings.com reports. They currently have a $4.
Ladenburg Thalmann Financial Services Inc. Sells 7,373 Shares of Amneal Pharmaceuticals Inc (NYSE:AMRX)
10:58am, Sunday, 19'th Apr 2020
Ladenburg Thalmann Financial Services Inc. lowered its stake in shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) by 17.0% during the fourth quarter, Holdings Channel.com reports. The firm owned 36,094
Cubist Systematic Strategies LLC Sells 40,394 Shares of Amneal Pharmaceuticals Inc (NYSE:AMRX)
08:16am, Sunday, 19'th Apr 2020
Cubist Systematic Strategies LLC lessened its holdings in shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) by 62.7% during the 4th quarter, according to the company in its most recent disclosure with
Amneal Pharmaceuticals Inc (NYSE:AMRX) Shares Bought by Alliancebernstein L.P.
09:20am, Saturday, 18'th Apr 2020
Alliancebernstein L.P. raised its holdings in Amneal Pharmaceuticals Inc (NYSE:AMRX) by 3.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 233,249 shares of
Research Analysts Issue Forecasts for Amneal Pharmaceuticals Inc's FY2020 Earnings (NYSE:AMRX)
07:44am, Saturday, 18'th Apr 2020
Amneal Pharmaceuticals Inc (NYSE:AMRX) – Equities research analysts at Piper Sandler cut their FY2020 earnings per share (EPS) estimates for Amneal Pharmaceuticals in a research report issued to cli
Q1 2020 EPS Estimates for Amneal Pharmaceuticals Inc Decreased by Piper Sandler (NYSE:AMRX)
06:28am, Saturday, 18'th Apr 2020
Amneal Pharmaceuticals Inc (NYSE:AMRX) – Piper Sandler dropped their Q1 2020 earnings per share (EPS) estimates for Amneal Pharmaceuticals in a note issued to investors on Tuesday, April 14th. Piper
Amneal Pharmaceuticals Inc (NYSE:AMRX) Short Interest Up 17.6% in March
09:02am, Friday, 17'th Apr 2020
Amneal Pharmaceuticals Inc (NYSE:AMRX) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 6,230,000 shares, an incr
RBC Capital Maintains a Hold Rating on Amneal Pharmaceuticals (AMRX)
05:52pm, Thursday, 16'th Apr 2020
In a report released yesterday,
Randall Stanicky
from RBC Capital maintained a
Hold
rating on Amneal Pharmaceuticals (
AMRX
–
Research Report
), with a price target of
$4.00
. The company’s shares
Eagle Pharma's Ryanodex shows in vitro antiviral activity against COVID-19 EGRX;AMRX
11:37am, Thursday, 16'th Apr 2020
Eagle Pharma's Ryanodex shows in vitro antiviral activity against COVID-19 EGRX AMRX
BRIEF-Amneal Launches Generic Butrans Following ANDA Approval By FDA
11:16am, Thursday, 16'th Apr 2020
Amneal Pharmaceuticals Inc:
Amneal Launches Generic Butrans Following ANDA Approval by FDA
11:00am, Thursday, 16'th Apr 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) ("Amneal" or the "Company") today announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ("Eagle"), a New Jersey-based pharmaceutical company, today announced that its product RYANODEX® (dantrolene sodium) for injectable suspension inhibited the
Bank of America Corp DE Increases Position in Amneal Pharmaceuticals Inc (NYSE:AMRX)
09:26am, Thursday, 16'th Apr 2020
Bank of America Corp DE raised its holdings in Amneal Pharmaceuticals Inc (NYSE:AMRX) by 205.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fu
Amneal Pharmaceuticals Moving to a Virtual Meeting Format for 2020 Annual Meeting of Stockholders
08:30pm, Wednesday, 15'th Apr 2020
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) ("Amneal" or the "Company") today announced that its 2020 Annual Meeting of Stockholders (the "Annual Meeting") will be a virtual meeting instead of an in-per
Bank of New York Mellon Corp Has $6.37 Million Holdings in Amneal Pharmaceuticals Inc (NYSE:AMRX)
09:42am, Wednesday, 15'th Apr 2020
Bank of New York Mellon Corp lifted its stake in shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) by 147.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The instituti
